Strategic Partnerships Substipharm already engages in strategic manufacturing and distribution collaborations, notably with Emergent BioSolutions for Japanese Encephalitis vaccine and Zuellig Pharma for regional commercialization. Leverage these existing channels to explore co-developed vaccines, licensed products, or regional manufacturing partnerships to expand market access and portfolio breadth.

Global Reach Active in more than 90 countries with a diverse portfolio of over 90 molecules and 50+ development projects. Target multinational distributors and regional pharmas in high-growth markets for licensing, contract manufacturing, or exclusive distribution agreements to capitalize on their international footprint.

Vaccine & Biologics Focus Strong involvement in vaccines and biological products, including Japanese Encephalitis vaccines and related drug substance manufacturing. Prioritize opportunities in vaccine supply, contract manufacturing, and biologics partnerships, especially with government and defense or urban immunization programs seeking reliable partners.

Mature & OTC Portfolio A mix of mature brands, generics, and OTC products enables cross-selling and portfolio bundling opportunities in new markets. Propose bundled tenders, private-label options, or joint marketing initiatives to expand reach in regions where price-conscious and accessible healthcare products are in demand.

Digital & Data Enablement Adopted tech stack including Salesforce, Power Platform, SharePoint, and analytics tools. Use these capabilities to enable seamless partner onboarding, track performance dashboards, and deliver data-driven sales proposals. Highlight readiness for partner portals, API integrations, and collaborative marketing campaigns.